New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

Topic

Health

Utilities consumer staples and healthcare
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities

Here's what you need to know about the three defensive sectors in the S&P 500

Latest news about Health

Obesity and Weight-Loss Drugs: A New Thematic ETF Segment?

The ongoing Ozempic and weight-loss drug obsession has investors and ETF issuers turning to new ways of gaining healthcare sector exposure.

Weight-loss-drugs

Healthcare Stocks Drop on Medicare Payment Rate Surprise

Shares of major U.S. health insurers have taken a significant hit as the final 2025 Medicare Advantage plan payment rates fall short of industry expectations, raising concerns about margins.

Healthcare ETFs drop

Notable ETF Filings Recap: March 2024

Here's a look at some of the most interesting prospective ETFs awaiting regulatory review and approval as of March.

Files and documents piles

Healthcare Funds on the Rise

Health Care sector sees a modest 2023 finish after a decline in 2022, sparking renewed interest with substantial inflows this week.

refill of liquid on tubes

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Ozempic, Wegovy, and Mounjaro – here's how the latest weight-loss drugs could affect some pharmaceutical and food ETFs.

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Upside & Impact Ep. 4 - What Happened to the Beyond Meat and Oatly stocks?

Dr. Sasha Goodman, Chief Investment Officer of VegTech Invest, joins Elysabeth Alfano, CEO of VegTech Invest to discuss what has happened to the Beyond Meat and Oatly stocks and, conversely, the large landscape of Plant-based Innovation companies in the public markets that are thriving.

Upside & Impact Ep. 4 - What Happened to the Beyond Meat and Oatly stocks?

Two biotech ETFs to watch for the rest of 2022 and beyond

Investors with a high tolerance for risk may seek to gain exposure to the growth potential of the biotech industry. We take a look at two ETFs that have rallied over the last month.

Two biotech ETFs to watch for the rest of 2022 and beyond
Advertisement
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring

Asset TV

The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring

Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.

Asset TV
By Asset TV · March 6, 2026
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)

What’sTheFund

What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)

Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).

NYSE logo
By NYSE · March 6, 2026
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)

What’sTheFund

What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)

Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).

NYSE logo
By NYSE · March 6, 2026
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)

What’sTheFund

What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)

Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).

NYSE logo
By NYSE · March 6, 2026

Browse all educational columns

Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast